These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26543745)
1. CXCL1 is elevated in the urine of bladder cancer patients. Burnier A; Shimizu Y; Dai Y; Nakashima M; Matsui Y; Ogawa O; Rosser CJ; Furuya H Springerplus; 2015; 4():610. PubMed ID: 26543745 [TBL] [Abstract][Full Text] [Related]
2. CCL18 in a multiplex urine-based assay for the detection of bladder cancer. Urquidi V; Kim J; Chang M; Dai Y; Rosser CJ; Goodison S PLoS One; 2012; 7(5):e37797. PubMed ID: 22629457 [TBL] [Abstract][Full Text] [Related]
3. Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer. Nakashima M; Matsui Y; Kobayashi T; Saito R; Hatahira S; Kawakami K; Nakamura E; Nishiyama H; Ogawa O Cancer Biomark; 2015; 15(4):357-64. PubMed ID: 26406865 [TBL] [Abstract][Full Text] [Related]
4. IL-8 as a urinary biomarker for the detection of bladder cancer. Urquidi V; Chang M; Dai Y; Kim J; Wolfson ED; Goodison S; Rosser CJ BMC Urol; 2012 May; 12():12. PubMed ID: 22559832 [TBL] [Abstract][Full Text] [Related]
5. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker. Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081 [TBL] [Abstract][Full Text] [Related]
6. Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers. Miyake M; Lawton A; Goodison S; Urquidi V; Gomes-Giacoia E; Zhang G; Ross S; Kim J; Rosser CJ BMC Cancer; 2013 Jul; 13():322. PubMed ID: 23815949 [TBL] [Abstract][Full Text] [Related]
7. Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer. Vu Van D; Heberling U; Wirth MP; Fuessel S Oncol Lett; 2016 Nov; 12(5):3143-3152. PubMed ID: 27899974 [TBL] [Abstract][Full Text] [Related]
8. Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer. Liu C; Shi B; Hao C; Wang Q; Lv Q; Xing N; Shou J; Qu L; Gao Y; Qin C; Zhao J; Shou C Oncotarget; 2016 Jul; 7(28):43432-43441. PubMed ID: 27223068 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples. Zhou BF; Wei JH; Chen ZH; Dong P; Lai YR; Fang Y; Jiang HM; Lu J; Zhou FJ; Xie D; Luo JH; Chen W Oncotarget; 2016 Jul; 7(27):41703-41714. PubMed ID: 27203388 [TBL] [Abstract][Full Text] [Related]
10. Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method. Glukhov A; Potoldykova N; Taratkin M; Gordeev S; Polyakovsky K; Laukhtina E; Moschini M; Abufaraj M; Shariat SF; Sekacheva M; Enikeev D; Glybochko P J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33806392 [TBL] [Abstract][Full Text] [Related]
11. Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer. Miyake M; Lawton A; Goodison S; Urquidi V; Rosser CJ Pathol Res Pract; 2014 Feb; 210(2):74-8. PubMed ID: 24252309 [TBL] [Abstract][Full Text] [Related]
12. Urine interleukin-8 as a marker of vesicoureteral reflux in infants. Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M Pediatrics; 2006 May; 117(5):e863-7. PubMed ID: 16585276 [TBL] [Abstract][Full Text] [Related]
13. A multiplex immunoassay for the non-invasive detection of bladder cancer. Shimizu Y; Furuya H; Bryant Greenwood P; Chan O; Dai Y; Thornquist MD; Goodison S; Rosser CJ J Transl Med; 2016 Jan; 14():31. PubMed ID: 26830497 [TBL] [Abstract][Full Text] [Related]
14. Midkine Is a Potential Urinary Biomarker for Non-Invasive Detection of Bladder Cancer with Microscopic Hematuria. Lin H; Zhou Q; Wu W; Ma Y Onco Targets Ther; 2019; 12():11765-11775. PubMed ID: 32099383 [TBL] [Abstract][Full Text] [Related]
15. Urinary Free Glycosaminoglycans Identify Adults at High Risk of Developing Early-stage High-grade Bladder Cancer. Gatto F; Bratulic S; Maccari F; Galeotti F; Volpi N; Nielsen J; Lotan Y; Kjölhede H Eur Urol Open Sci; 2024 Oct; 68():40-47. PubMed ID: 39263348 [TBL] [Abstract][Full Text] [Related]
16. Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies. Chen D; Xu J; Zhang Q Oncol Rep; 2018 Jun; 39(6):2817-2828. PubMed ID: 29658613 [TBL] [Abstract][Full Text] [Related]
17. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis? Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999 [TBL] [Abstract][Full Text] [Related]
18. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer. Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis. Chen L; Cui Z; Liu Y; Bai Y; Lan F Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]